SEC Form 4 · accession 0001144204-18-062710
Cellectar Biosciences, Inc. · CLRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V Caruso
Officer — President and CEO · Director
Period of report
Nov 30, 2018
Accepted (ET)
Nov 30, 2018 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share | Nov 30, 2018 | P | 1,000 | $2.282 | A | 22,354 | D |
Table II — derivative securities
No Table II lines on this filing.